Delivery Order SPE2DB25D3109-SPE2DB26FP4PA
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,137.57 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract is set to conclude on October 27, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. As a non-set-aside procurement, the award reflects AmerisourceBergen's continued role as a critical pharmaceutical supplier within the federal...
- The Defense Logistics Agency awarded a $6,987.59 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections. This is a firm fixed-price contract with an ultimate completion date of September 16, 2025, and represents a non-set-aside award issued through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,070.07 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 10 mg/0.5 mL pens (semaglutide injection). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 30, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections, with a ceiling value of $2,853.49 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order under a non-competitive, non-set-aside award, with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of...
- The Defense Logistics Agency awarded a $35,903.76 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 ml pen injectors. This firm fixed-price contract, with an ultimate completion date of October 28, 2025, represents a pediatric formulation delivery supporting federal medical supply needs. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $15,944.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injections. This firm fixed-price delivery order, valued at $5,742.46, represents a non-competitive set-aside award and is scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $17,465.56 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This firm fixed-price, competitively awarded contract is scheduled for completion by October 22, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...